In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market.
Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott’s leading life sciences lawyers. Beginning October 20, we’ll bring you a series of three pre-Symposium programs focused on today’s most pressing concerns for life sciences dealmakers, all culminating in a half-day virtual program with multiple networking sessions, industry-leading keynote speakers and insights from investors, life sciences executives, policy experts and investment bankers.
Keynote Speakers:
Scott Gottlieb, M.D., Physician; Former Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS
Dr. Michelle McMurry-Heath, President & CEO, Biotechnology Innovation Organization
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
